Correction to: Pharmacological Rescue With SR8278, A Circadian Nuclear Receptor REV-ERBα Antagonist As A Therapy for Mood Disorders In Parkinson’s Disease (Neurotherapeutics, (2022), 10.1007/s13311-022-01215-w)

Jeongah Kim, Inah Park, Sangwon Jang, Mijung Choi, Doyeon Kim, Woong Sun, Youngshik Choe, Ji Woong Choi, Cheil Moon, Sung Ho Park, Han Kyoung Choe, Kyungjin Kim

Research output: Contribution to journalComment/debatepeer-review

Abstract

The article “Pharmacological Rescue with SR8278, a Circadian Nuclear Receptor REV-ERBα Antagonist as a Therapy for Mood Disorders in Parkinson’s Disease”, written by Jeongah Kim, Inah Park, Sangwon Jang, Mijung Choi, Doyeon Kim, Woong Sun, Youngshik Choe, Ji-Woong Choi, Cheil Moon, Sung Ho Park, Han Kyoung Choe, Kyungjin Kim was originally published electronically on the publisher’s internet portal on 23 March 2022 without open access.

Original languageEnglish
JournalNeurotherapeutics
DOIs
Publication statusAccepted/In press - 2022

ASJC Scopus subject areas

  • Pharmacology
  • Clinical Neurology
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Correction to: Pharmacological Rescue With SR8278, A Circadian Nuclear Receptor REV-ERBα Antagonist As A Therapy for Mood Disorders In Parkinson’s Disease (Neurotherapeutics, (2022), 10.1007/s13311-022-01215-w)'. Together they form a unique fingerprint.

Cite this